Paracaine and Albuterol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paracaine (proparacaine hydrochloride) and Albuterol (albuterol). Common drug interactions include telangiectasia among females and cataract subcapsular among males.

The phase IV clinical study analyzes what interactions people have when they take Paracaine and Albuterol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Paracaine?

Paracaine has active ingredients of proparacaine hydrochloride. eHealthMe is studying from 673 Paracaine users. Check the latest studies of Paracaine.

What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,052 Albuterol users. Check the latest studies of Albuterol.



On Jul, 12, 2026

12 people who take Paracaine and Albuterol together, and have interactions are studied.

Paracaine and Albuterol drug interactions.

What are the common drug interactions of Paracaine and Albuterol, by gender? *:

female:

  1. Telangiectasia (small dilated blood vessels near the surface of the skin)
  2. Tooth injury
  3. Type 2 diabetes mellitus
  4. Venous stenosis (abnormal narrowing of veins)
  5. Vomiting
  6. Wheezing (a high-pitched whistling sound made while you breath)
  7. Chills (felling of cold)
  8. Anxiety
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

male:

  1. Cataract subcapsular (cataracts that affect the back of the lens)
  2. Chronic kidney disease
  3. Hypopyon (pus in the eye)
  4. Renal injury (kidney injury)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Ulcerative keratitis (ulcerative inflammation of the cornea)
  7. Visual impairment
  8. Anaemia (lack of blood)
  9. Blood urine present
  10. Ciliary hyperaemia (excessive accumulation of blood in a part of inside of eye tissue)

What are the common drug interactions of Paracaine and Albuterol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Corneal thinning
  2. Eyelid ptosis (falling of the upper or lower eyelid)
  3. Mydriasis (a dilation of the pupil)
  4. Cataract subcapsular (cataracts that affect the back of the lens)
  5. Corneal deposits
  6. Corneal epithelium defect (outer layer defect of cornea)
  7. Corneal infiltrates (small hazy greyish areas of cornea)
  8. Corneal neovascularisation (excessive ingrowths of blood vessels into the cornea)
  9. Corneal oedema (corneal swelling)
  10. Corneal opacity (scarring or clouding of the cornea)

20-29:

  1. Corneal abscess (a collection of pus in cornea)
  2. Corneal epithelium defect (outer layer defect of cornea)
  3. Corneal thinning
  4. Cough
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Drug abuse
  7. Drug hypersensitivity
  8. Erythema of eyelid (redness of the eyelid)
  9. Eye irritation
  10. Eyelid oedema (eyelids are swollen and contain excessive fluid)

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Blood urine present
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Haematochezia (passage of stools containing blood)
  5. Ulcer haemorrhage (bleeding ulcer)

60+:

  1. Chronic kidney disease
  2. Chills (felling of cold)
  3. Bone pain
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Clavicle fracture
  6. Death
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Diarrhoea
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Pain: 4 people, 33.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 33.33%
  3. Stress And Anxiety: 2 people, 16.67%
  4. Keratoconus (a condition in which your eye's cornea is unable to hold its round shape): 2 people, 16.67%
  5. Inflammation: 2 people, 16.67%
  6. Fungal Infection: 2 people, 16.67%
  7. Bacterial Infection: 2 people, 16.67%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 16.67%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%
  10. High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Paracaine and Albuterol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paracaine and Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paracaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paracaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Albuterol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on proparacaine hydrochloride and albuterol (the active ingredients of Paracaine and Albuterol, respectively), and Paracaine and Albuterol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: